-
-
-
ISO 9001:2015 CERTIFIED
ISO 9001:2015 CERTIFIED
Ponatinib is a tyrosine kinase inhibitor used in the treatment of Philadelphia chromosome–positive (Ph+) chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL), including resistant or refractory cases. It works by inhibiting BCR-ABL kinase and other kinases, suppressing malignant cell proliferation. Ponatinib API is produced under GMP standards and is suitable for oral solid dosage formulations, including tablets.
Ponatinib API is manufactured and supplied by Artis Biotech | ASTANDARDS, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.
Total Products : 6 (Page 1 of 1)
CAT No.: AS04482
CAS No.: 2227480-51-3
Category: Metabolites
Parent API: Ponatinib
Mol. Formula: C13H18F3N3
Mol. Wt.: 548.57
CAT No.: AS04485
CAS No.: 1356385-96-0
Category: Impurities
Parent API: Ponatinib
Mol. Formula: C13H17N3O7S2
Mol. Wt.: 291.3
CAT No.: AS04484
CAS No.: 1300690-48-5
Category: Impurities
Parent API: Ponatinib
Mol. Formula: C17H13N3O2
Mol. Wt.: 277.28
CAT No.: AS04483
CAS No.: 694499-26-8
Category: Impurities
Parent API: Ponatinib
Mol. Formula: C16H11N3O2
Mol. Wt.: 273.3
CAT No.: AS04481
CAS No.: 1114544-31-8
Category: Working Standards
Parent API: Ponatinib
Mol. Formula: C29H27F3N6O2
Mol. Wt.: 569.02
CAT No.: AC0321
CAS No.: 1562993-37-6
Category: Deuterated Standards
Parent API: Ponatinib
Mol. Formula: C29H19D8F3N6O
Mol. Wt.: 540.62
